Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Shire announces name change

Shire announces name change

2nd October 2008

Shire Limited has announced the results of its recent annual general meeting held last month, including a change in the company name to Shire plc.

The resolution to rename the global speciality biopharmaceutical company was passed by 331,323,817 to 31,609, with 159,462 votes being withheld.

Also at the meeting, Matthew Emmens, Angus Russell, Graham Hetherington, Barry Price, David Kappler, Jeffrey Leiden, Patrick Langlois, Kate Nealon, David Mott and Michael Rosenblatt were elected as directors of the firm.

Other motions passed that the meeting included the re-appointment of Deloitte & Touche as auditors of the firm and the authorisation of the audit, compliance and risk committee to determine their remuneration.

“Two copies of all resolutions passed, other than resolutions concerning ordinary business, will shortly be submitted to the UK Listing Authority and will be available for inspection at the UK Listing Authority’s Document Viewing Facility,” Shire said.

It added its change in name would be effective as of the start of October 2008, following the registration of this change with Companies Registry in Jersey.

Last month, Shire announced the elections for its interim dividend in respect of the half-year period ending June 2008, having announced an interim dividend of 2.147 cents (0.012p) per ordinary share in July 2008.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.